Glutathione and cellular resistance to anti-cancer drugs.
Hedley
D
D
Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada.
Chow
S
S
D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001643:Bridged Bicyclo Compounds; D002460:Cell Line; D004351:Drug Resistance; D005434:Flow Cytometry / Q000379:methods* / Q000592:standards; D005978:Glutathione / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D005982:Glutathione Transferase / Q000378:metabolism; D006801:Humans; D051379:Mice; D015335:Molecular Probes; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D010663:Phenylmercury Compounds; D011720:Pyrazoles; D012015:Reference Standards; D013194:Staining and Labeling / Q000379:methods
D000970:Antineoplastic Agents; D001643:Bridged Bicyclo Compounds; D015335:Molecular Probes; D010663:Phenylmercury Compounds; D011720:Pyrazoles; C059597:monochlorobimane; D005982:Glutathione Transferase; D005978:Glutathione; C028381:monobromobimane; C031504:mercury orange